News

The rules governing minor changes to labeling and patient information leaflets can cost individual companies thousands of pounds and these costs are often passed on to the consumer

Previous studies had shown that people who regularly take nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, are less likely to develop Parkinson’s disease. These results prompted the Mayo

Evotec’s EVT 101 is an NR2B subtype-specific NMDA receptor antagonist developed for the treatment of Alzheimer’s disease and/or neuropathic pain. A total of 90 healthy subjects, both young

The findings, published in the online edition of the Proceedings of the National Academy of Sciences, provide the basis for further development of a safe and effective treatment

Experiments conducted by the University of Texas Medical Branch (UTMB) scientists show that a SARS coronavirus protein called nsp1 causes the breakdown of biochemical messages that normally prompt

Clinical trial site initiations and the enrollment of women for the trial began in late July, after Third Wave came to an agreement with the FDA on the

NanoBio has developed multiple topical anti-infective products and vaccine candidates derived from its patented NanoStat technology platform. Products developed from the technology have a unique ability to penetrate

Major participating investors included Forward Ventures, Lilly Ventures, and Novo A/S. The funding will be used to advance the clinical development of Calsed (amrubicin hydrochloride), Cabrellis’ third-generation anthracycline,

The randomized, double-blind, placebo-controlled phase II trial is expected to enroll approximately 72 patients with pulmonary hypertension (PH) associated with chronic obstructive pulmonary disease (COPD). The primary endpoint